AI English summary of an SEC filing — figures as filed
Brown-Forman BF.BBrown-Forman said net sales for the 6 months ended October 31, 2025 were $2.0 billion, down $86 million (4%), and operating income was $565 million, down $57 million (9%). The company cited unfavorable price/mix as a factor in the net sales decline and said volume was flat.
Key points
AI summaryBrown-Forman said net sales for the 6 months ended October 31, 2025 were $2.0 billion, down $86 million (4%), and operating income was $565 million, down $57 million (9%). The company cited unfavorable price/mix as a factor in the net sales decline and said volume was flat.
Brown-Forman said it expects organic net sales and organic operating income for fiscal 2026 to decline in the low-single digit range. It also updated its estimated capital expenditures range to $110 to $120 million, from a prior range of $125 to $135 million.
The company said cash provided by operating activities for the 6 months ended October 31, 2025 was $292 million, up $163 million. Cash used for financing activities was $399 million, reflecting an increase of $167 million in net repayment of short-term borrowings and an increase of $99 million in share repurchases.
Brown-Forman said its Board of Directors approved on October 1, 2025 a repurchase program for Class A and Class B shares of $400 million. The company repurchased $99 million in October 2025 and an additional $167 million through November 30, 2025 after quarter end, leaving approximately $134 million remaining.
Key figures
Quarter ended October 31, 2025
- Revenue
- $1.0B
- Operating income
- $305M
- Net income
- $224M
- EPS
- $0.47
- Gross profit
- $615M
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Net sales and operating income for the 6 months ended October 31, 2025
Brown-Forman said net sales for the 6 months ended October 31, 2025 were $2.0 billion, down $86 million (4%), and operating income was $565 million, down $57 million (9%). The company cited unfavorable price/mix as a factor in the net sales decline and said volume was flat.
Source · Based on the MD&A text of the filing
Fiscal 2026 organic outlook and capital expenditures range
Brown-Forman said it expects organic net sales and organic operating income for fiscal 2026 to decline in the low-single digit range. It also updated its estimated capital expenditures range to $110 to $120 million, from a prior range of $125 to $135 million.
Source · Based on the MD&A text of the filing
Cash flow and financing activities for the 6 months
The company said cash provided by operating activities for the 6 months ended October 31, 2025 was $292 million, up $163 million. Cash used for financing activities was $399 million, reflecting an increase of $167 million in net repayment of short-term borrowings and an increase of $99 million in share repurchases.
Source · Based on the MD&A text of the filing
$400 million repurchase program and actual repurchases
Brown-Forman said its Board of Directors approved on October 1, 2025 a repurchase program for Class A and Class B shares of $400 million. The company repurchased $99 million in October 2025 and an additional $167 million through November 30, 2025 after quarter end, leaving approximately $134 million remaining.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…